Low glutathione peroxidase activity levels in patients with vitiligo
- PMID: 25775636
- DOI: 10.2310/7750.2014.14076
Low glutathione peroxidase activity levels in patients with vitiligo
Abstract
Background: Vitiligo is an idiopathic skin disease characterized by white areas on the skin due to loss of the functional melanocytes, with possible involvement of oxidative stress. Glutathione peroxidase (GPx) is an antioxidant enzyme that protects cells against oxidative damage.
Aim: To examine serum GPx levels in patients with vitiligo and to relate the findings to the clinical features.
Patients and methods: The study group included 60 patients with vitiligo and 30 matching healthy controls. GPx activity was evaluated using enzyme-linked immunosorbent assay.
Results: We found a significant decrease in serum GPx activity level in the patients with vitiligo compared to the healthy controls (0.29 ± 0.14 versus 0.47 ± 0.13, p < .001). The levels were significantly low in skin phenotypes III and IV (p < .001). Higher levels were also observed with increasing age (≥ 14 years), prolonged disease duration (≥ 3 years), and generalized and extensive vitiligo (< 50%). However, these variations were statistically insignificant.
Conclusions: Low levels of serum GPx activity, indicative of a disturbed oxidant-antioxidant system, may contribute to the development of vitiligo.
© 2014 Canadian Dermatology Association.
Similar articles
-
Circulatory levels of antioxidants and lipid peroxidation in Indian patients with generalized and localized vitiligo.Arch Dermatol Res. 2009 Oct;301(10):731-7. doi: 10.1007/s00403-009-0964-4. Epub 2009 Jun 2. Arch Dermatol Res. 2009. PMID: 19488773
-
Analysis of myeloperoxidase promotor polymorphism and enzyme activity in Turkish patients with vitiligo.Eur J Dermatol. 2009 Nov-Dec;19(6):576-80. doi: 10.1684/ejd.2009.0793. Epub 2009 Sep 17. Eur J Dermatol. 2009. PMID: 19758957
-
The role of oxidants and antioxidants in generalized vitiligo at tissue level.J Eur Acad Dermatol Venereol. 2004 Nov;18(6):683-6. doi: 10.1111/j.1468-3083.2004.01080.x. J Eur Acad Dermatol Venereol. 2004. PMID: 15482295
-
Oxidant-antioxidant enzymes and lipid peroxidation in generalized vitiligo.Clin Exp Dermatol. 2004 Jul;29(4):406-9. doi: 10.1111/j.1365-2230.2004.01524.x. Clin Exp Dermatol. 2004. PMID: 15245542
-
Glutathione Peroxidase Level in Patients with Vitiligo: A Meta-Analysis.Biomed Res Int. 2016;2016:3029810. doi: 10.1155/2016/3029810. Epub 2016 Apr 27. Biomed Res Int. 2016. PMID: 27218102 Free PMC article. Review.
Cited by
-
From traditional medicine to nanomedicine: potential of Ginkgo biloba extracts in treating inflammatory skin diseases.RSC Med Chem. 2024 Jun 11;15(8):2643-2656. doi: 10.1039/d4md00194j. eCollection 2024 Aug 14. RSC Med Chem. 2024. PMID: 39149101 Review.
-
Serum Inflammatory and Oxidative Stress Markers in Patients with Vitiligo.J Clin Med. 2023 Sep 9;12(18):5861. doi: 10.3390/jcm12185861. J Clin Med. 2023. PMID: 37762802 Free PMC article.
-
Vitiligo and insulin resistance as a component of metabolic syndrome: an analysis.Postepy Dermatol Alergol. 2023 Aug;40(4):529-533. doi: 10.5114/ada.2023.126871. Epub 2023 Jun 12. Postepy Dermatol Alergol. 2023. PMID: 37692261 Free PMC article. Review.
-
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art.Int J Mol Sci. 2023 Mar 3;24(5):4910. doi: 10.3390/ijms24054910. Int J Mol Sci. 2023. PMID: 36902341 Free PMC article. Review.
-
Update on the pathogenesis of vitiligo.An Bras Dermatol. 2022 Jul-Aug;97(4):478-490. doi: 10.1016/j.abd.2021.09.008. Epub 2022 May 25. An Bras Dermatol. 2022. PMID: 35643735 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
